Cargando…
Translational Pharmacokinetic–Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose
MK-2075 is a small-molecule selective inhibitor of the NaV1.7 channel investigated for the treatment of postoperative pain. A translational strategy was developed for MK-2075 to quantitatively interrelate drug exposure, target modulation, and the desired pharmacological response in preclinical anima...
Autores principales: | Ballard, Jeanine E., Pall, Parul S., Vardigan, Joshua, Zhao, Fuqiang, Holahan, Marie A., Zhou, Xiaoping, Jochnowitz, Nina, Kraus, Richard L., Klein, Rebecca M., Henze, Darrell A., Houghton, Andrea K., Burgey, Christopher S., Gibson, Christopher, Struyk, Arie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740778/ https://www.ncbi.nlm.nih.gov/pubmed/35002718 http://dx.doi.org/10.3389/fphar.2021.786078 |
Ejemplares similares
-
Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate
por: Ballard, Jeanine E., et al.
Publicado: (2020) -
Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects
por: Vardigan, Joshua D, et al.
Publicado: (2018) -
Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve
por: Klein, Rebecca M., et al.
Publicado: (2022) -
Gating Pore Currents in DIIS4 Mutations of NaV1.4 Associated with Periodic Paralysis: Saturation of Ion Flux and Implications for Disease Pathogenesis
por: Struyk, Arie F., et al.
Publicado: (2008) -
Immunotherapy – 2075. Towards a pan anti-allergy vaccine
por: Sabban, Sari
Publicado: (2013)